| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 5.959 | 18.392 | 31.281 | 30.846 | 94.483 |
| Total Income - EUR | - | - | - | - | - | 5.959 | 18.392 | 31.282 | 30.846 | 94.603 |
| Total Expenses - EUR | - | - | - | - | - | 1.133 | 5.944 | 6.281 | 19.662 | 12.934 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 4.826 | 12.448 | 25.001 | 11.185 | 81.669 |
| Net Profit/Loss - EUR | - | - | - | - | - | 4.652 | 11.907 | 24.252 | 10.898 | 78.887 |
| Employees | - | - | - | - | - | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Oncodiscovery S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 945 | 697 | 207 | 1.718 | 1.098 |
| Current Assets | - | - | - | - | - | 3.863 | 11.204 | 24.346 | 9.999 | 82.775 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 3.829 | 4.005 | 17.333 | 2.267 | 82.165 |
| Cash | - | - | - | - | - | 35 | 7.199 | 7.013 | 7.732 | 610 |
| Shareholders Funds | - | - | - | - | - | 4.693 | 11.948 | 24.293 | 10.939 | 78.927 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 137 | 84 | 321 | 785 | 4.995 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7210 - 7210" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oncodiscovery S.r.l.